Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of the treatment combination of the
commercially available chemotherapy drugs, docetaxel and liposomal doxorubicin, and a blood
thinner Enoxaparin on pancreatic cancer. The main goal of the study is to find out if this
combination chemotherapy and enoxaparin increases the number of individuals whose tumors
shrink.